Aristolochic acid nephropathy: a global public health issue that still needs attention

doi:10.3877/cma.j.issn.2095-3216.2018.01.002

Abstract

Abstract:

Aristolochic acid nephropathy (AAN) is not only a common chronic renal interstitial disease in China, but also one of the pathogenic factors of Balkan endemic nephropathy. Due to the disease involvement of a large geographic area and population, and the lack of effective treatment, a significant proportion of AAN patients progress to end-stage renal disease (ESRD), which has become a global public health problem. Strengthening the publicity, education, supervision, and management of AA nephrotoxicity, further exploring the pathogenesis of AAN, and seeking effective intervention targets have important scientific and practical significance for not only correct understanding and use of Chinese medicine, but also reducing the prevalence of ESRD.

Key words: Aristolochic acid (AA), Aristolochic acid nephropathy (AAN), Chinese herbs

Xiao Yang, Juan Wu, Xueqing Yu. Aristolochic acid nephropathy: a global public health issue that still needs attention[J]. Chinese Journal of Kidney Disease Investigation(Electronic Edition), 2018, 07(01): 4-7.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhsbyjdzzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2095-3216.2018.01.002

https://zhsbyjdzzz.cma-cmc.com.cn/EN/Y2018/V07/I01/4

References 28

[1]	Xu X, Nie S, Liu Z, et al. Epidemiology and clinical correlates of AKI in Chinese hospitalized adults [J]. Clin J Am Soc Nephrol, 2015, 10(9): 1510-1518.
[2]	Zhang J, Zhang L, Wang W, et al. Association between aristolochic acid and CKD: a cross-sectional survey in China [J]. Am J Kidney Dis, 2013, 61(6): 918-922.
[3]	Luciano RL, Perazella MA. Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatment [J]. Drug Saf, 2015, 38(1): 55-64.
[4]	Jelakovic B, Vukovic Lela I, Karanovic S, et al. Chronic dietary exposure to aristolochic acid and kidney function in native farmers from a Croatian endemic area and Bosnian immigrants [J]. Clin J Am Soc Nephrol, 2015, 10(2): 215-223.
[5]	Ng AWT, Poon SL, Huang MN, et al. Aristolochic acids and their derivatives are widely implicated in liver cancers in Taiwan and throughout Asia [J]. Sci Transl Med, 2017, 9 (421): pii：eaan6446
[6]	Debelle FD, Vanherweghem JL, Nortier JL. Aristolochic acid nephropathy: a worldwide problem [J]．Kidney Int, 2008, 74(2): 158-169.
[7]	Bracinska H, Bárta F, Levová K, et al. Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo [J]. Toxicology, 2016, 344-346: 7-18.
[8]	Stiborova M, Frei E, Arlt VM, et al. Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy [J]. Mutat Res, 2008, 658 (1-2): 55-67.
[9]	Xue X, Gong LK, Maeda K, et al. Critical role of organic anion transporters 1 and 3 in kidney accumulation and toxicity of aristolochic acid I [J]. Mol Pharm, 2011, 8(6): 2183-2192.
[10]	Zeng Y, Zhang R, Wu J, et al. Organic anion transporter 1(OAT1) involved in renal cell transport of aristolochic acid I[J]. Hum Exp Toxicol, 2012, 31(8): 759-770.
[11]	张锐，阳晓，刘眉，等. 肾小管上皮细胞有机阴离子转运蛋白1在马兜铃酸Ⅰ跨细胞转运及其在细胞毒性中的作用[J]. 中华肾脏病杂志，2009, 25 (8): 624-629.
[12]	Baudoux TE, Pozdzik AA, Arlt VM, et al. Probenecid prevents acutetubular necrosis in a mouse model of aristolochic acid nephropathy [J]. Kidney Int, 2012, 82 (10): 1105-1113.
[13]	Yu FY, Wu TS, Chen TW, et al. Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells [J]. Toxicol In Vitro, 2011, 25 (4): 810-816.
[14]	Qi X, Cai Y, Gong L, et al. Role of mitochondrial permeability transition in human renal tubular epithelial cell death induced by aristolochic acid [J]. Toxicol Appl Pharmacol, 2007, 222 (1): 105-110.
[15]	Zeng Y, Li S, Wu J, et al. Autophagy inhibitors promoted aristolochic acid I induced renal tubular epithelial cell apoptosis via mitochondrial pathway but alleviated nonapoptotic cell death in mouse acute aristolochic acid nephropathy model [J]. Apoptosis, 2014, 19 (8): 1215-1224.
[16]	Matsui K, Kamijo-Ikemorif A, Sugaya T, et al. Renal liver-type fatty acid binding protein (L-FABP) attenuates acute kidney injury in aristolochic acid nephrotoxicity [J]. Am J Pathol, 2011, 178(3): 1021-1032.
[17]	Wu J, Liu X, Fan J, et al. Bardoxolone methyl (BARD) ameliorates aristolochic acid (AA)-induced acute kidney injury through Nrf2 pathway [J]. Toxicology, 2014, 318: 22-31.
[18]	Fougeray S, Pallet N. Mechanisms and biological functions of autophagy in diseased and ageing kidneys [J]. Nat Rev Nephrol, 2015, 11(1): 34-45.
[19]	Zeng Y, Yang X, Wang J, et al. Aristolochic acid I induced autophagy extenuates cell apoptosis via ERK 1/2 pathway in renal tubular epithelial cells [J]. PLoS One, 2012, 7 (1): e30312.
[20]	Yang CC, Wu CT, Chen LP, et al. Autophagy induction promotes aristolochic acid-I-induced renal injury in vivo and in vitro [J]. Toxicology, 2013, 312: 63-73.
[21]	Li Y, Liu Z, Guo X, et al. Aristolochic acid I-induced DNA damage and cell cycle arrest in renal tubular epithelial cells in vitro [J]. Arch Toxicol, 2006, 80(8): 524-532.
[22]	Yang L, Besschetnova TY, Brooks CR, et al. Epithelial cell cycle arrest in G2/M mediates kidney fibrosis after injury [J]. Nat Med, 2010, 16(5): 535-543.
[23]	Jenkins RH, Davies LC, Taylor PR, et al. miR-192 induces G/M growth arrest in aristolochic acid nephropathy[J]. Am J Pathol, 2014, 184(4): 996-1009.
[24]	Novitskaya T, Mcdermott L, Zhang KX, et al. A PTBA small molecule enhances recovery and reduces postinjury fibrosis after aristolochic acid-induced kidney injury [J]. Am J Physiol Renal Physiol, 2014, 306 (5): 496-504.
[25]	Zhou L, Fu P, Huang XR, et al. Mechanism of chronic aristolochic acid nephropathy: role of Smad3 [J]. Am J Physiol Renal Physiol, 2010, 298(4): 1006-1017.
[26]	Liu M, Yang X, Fan J, et al. Altered tight junctions and fence function in NRK-52E cells induced by aristolochic acid [J]. Hum Exp Toxicol, 2012, 31 (1): 32-41.
[27]	Campanholle G, Ligresti G, Gharib SA, et al. Cellular mechanisms of tissue fibrosis. 3. Novel mechanisms of kidney fibrosis [J]. Am J Physiol Cell Physiol, 2013, 304(7): C591-C603.
[28]	Bai Y, Lu H, Hu L, et al. Effect of Sedum sarmentosum BUNGE extract on aristolochic acid-induced renal tubular epithelial cell injury [J]. J Pharmacol Sci, 2014, 124(4): 445-56.

Please choose a citation manager

Content to export